Trials Sponsors Conditions Drugs Pricing

Conditions

Gastroparesis Due to Diabetes Mellitus Type I Type 1 Diabetes

Keywords

type 1 diabetesgastroparesis

Outcome Measures

Primary Outcomes (1)

Time in Range (70-180 mg/dL)
Percentage of time that sensor glucose values are within the target range of 70-180 mg/dL, as measured by continuous glucose monitoring (CGM).
Baseline to 3 months

Secondary Outcomes (6)

HbA1c
Baseline to 3 months
Mean Sensor Glucose
Baseline to 3 months
Time in Tight Target Range (70-140 mg/dL)
Baseline to 3 months
Time Above Range
Baseline to 3 months
Time Below Range
Baseline to 3 months
+1 more secondary outcomes

Other Outcomes (2)

Severe Hypoglycemia
3 months
Diabetic Ketoacidosis
3 months

Study Arms (2)

Medtronic 780G group

EXPERIMENTAL

Device: Medtronic 780G AID

Usual care

NO INTERVENTION

Participants will continue either multiple daily injections or non-AID insulin pumps

Interventions

Medtronic 780G AIDDevice

Participants in Medtronic AID treatment group will use it for three months

Medtronic 780G group

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Age ≥18 years
Diagnosis of T1D for at least 12 months with stable insulin regimen for at least 2 months

Sponsors & Collaborators

Viral N. Shah
Otherlead
Medtronic
Industrycollaborator

Study Sites (1)

Indiana University Health, Univeristy hospital

Indianapolis, Indiana, 46202, United States

RECRUITING

Zunera Tariq, MDCONTACT317-278-0907 tariqz@iu.edu

Viral Shah, MDCONTACT317-278-6017 tariqz@iu.edu

Viral Shah, MDPRINCIPAL INVESTIGATOR

Zunera Tariq, MDSUB INVESTIGATOR

MeSH Terms

Conditions

Diabetes Mellitus, Type 1Gastroparesis

Interventions

Insemination, Artificial, Heterologous

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System DiseasesStomach DiseasesGastrointestinal DiseasesDigestive System DiseasesParalysis

Central Study Contacts

Sana Kalaji

CONTACT

317-278-6017 skalaji@iu.edu

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: NONE
Purpose: TREATMENT
Intervention Model: PARALLEL
Sponsor Type: OTHER
Responsible Party: SPONSOR INVESTIGATOR
PI Title: Principal Investigator

Study Record Dates

First Submitted

December 14, 2025

First Posted

December 17, 2025

Study Start

February 9, 2026

Actual (reported)

Primary Completion

March 1, 2027

Estimated

To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (6)

Other Outcomes (2)

Study Arms (2)

Medtronic 780G group

Usual care

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Intervention Hierarchy (Ancestors)

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (6)

Other Outcomes (2)

Study Arms (2)

Medtronic 780G group

Usual care

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Intervention Hierarchy (Ancestors)

Data Sharing

Source record

Locations